NCT02705768View on ClinicalTrials.gov

Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2017

Conditions
Seizures, Focal
Interventions
DRUG

Carbamazepine

Carbamazepine will be started with a dose of 200 mg/day for one week and then increased to 400 mg/day for one week and then 600mg/day for next two weeks.

DRUG

Oxcarbazepine

Oxcarbazepine will be started with 10mg/kg daily dose for one week followed by 15mg/kg daily for next one week and then will be increased to 20mg/kg for next two weeks.

Trial Locations (1)

751019

AIIMS, Bhubaneswar, Bhubaneswar

All Listed Sponsors
lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER

NCT02705768 - Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures | Biotech Hunter | Biotech Hunter